Published in Immunol Today on May 01, 1983
Increased fetal loss in women with heritable thrombophilia. Lancet (1996) 3.34
Photoreceptor protein from the purple membrane of Halobacterium halobium. Molecular weight and retinal binding site. Biochemistry (1976) 3.08
Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature (1991) 2.67
Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature (1988) 2.46
Peripheral deletion of self-reactive B cells. Nature (1991) 2.34
Thrombophilia in pregnancy: a systematic review. Br J Haematol (2006) 2.33
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost (2005) 2.13
SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis. J Clin Invest (1988) 1.90
Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. Arch Intern Med (2001) 1.82
Too much of a good thing: why it is bad to stimulate the beta cell to secrete insulin. Diabetologia (2008) 1.79
Molecular cloning of a member of the gene family that encodes pMGA, a hemagglutinin of Mycoplasma gallisepticum. Infect Immun (1993) 1.75
Thromboplastin related differences in the determination of international normalised ratio: a cause for concern? Steering Committee of the UK National External Quality Assessment Scheme in Blood Coagulation. Thromb Haemost (1994) 1.67
Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen. J Biol Chem (1987) 1.54
Molecular cloning and characterization of the novel, human complement-associated protein, SP-40,40: a link between the complement and reproductive systems. EMBO J (1989) 1.52
Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism. Blood Coagul Fibrinolysis (2000) 1.50
Peripheral T cell tolerance. Annu Rev Immunol (1992) 1.47
Familial thrombophilia and lifetime risk of venous thrombosis. J Thromb Haemost (2004) 1.44
Injecting drug use is a risk factor for deep vein thrombosis in women in Glasgow. Br J Haematol (2001) 1.44
The nu gene acts cell-autonomously and is required for differentiation of thymic epithelial progenitors. Proc Natl Acad Sci U S A (1996) 1.43
Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy. Lancet (1998) 1.43
Clonal deletion of autospecific B lymphocytes. Immunol Rev (1991) 1.42
An idiotypic determinant formed by both immunoglobulin constant and variable regions. Nature (1983) 1.42
The organisation of the multigene family which encodes the major cell surface protein, pMGA, of Mycoplasma gallisepticum. FEBS Lett (1994) 1.41
Deletion of 24 amino acids from the pro-alpha 1(I) chain of type I procollagen in a patient with the Ehlers-Danlos syndrome type VII. J Biol Chem (1986) 1.41
Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur J Immunol (1995) 1.40
Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight. Lancet (1999) 1.40
Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun (2000) 1.38
Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost (1997) 1.37
Partial primary structure of the T4 antigens of mouse and sheep: assignment of intrachain disulfide bonds. Proc Natl Acad Sci U S A (1986) 1.36
Expression studies on four members of the pMGA multigene family in Mycoplasma gallisepticum S6. Microbiology (1995) 1.36
Characterization of a major hemagglutinin protein from Mycoplasma gallisepticum. Infect Immun (1992) 1.35
Blood loss with knee joint replacement. J R Coll Surg Edinb (1981) 1.33
Expression of the pMGA genes of Mycoplasma gallisepticum is controlled by variation in the GAA trinucleotide repeat lengths within the 5' noncoding regions. Infect Immun (1998) 1.31
Prevalence of protein C deficiency in the healthy population. Thromb Haemost (1995) 1.28
HLA genes associated with autoimmunity and progression to disease in type 1 diabetes. Tissue Antigens (2003) 1.28
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess (2006) 1.27
Mycoplasma synoviae has two distinct phase-variable major membrane antigens, one of which is a putative hemagglutinin. Infect Immun (1997) 1.26
Expression of two members of the pMGA gene family of Mycoplasma gallisepticum oscillates and is influenced by pMGA-specific antibodies. Infect Immun (1998) 1.25
Immunological tolerance: new approaches using transgenic mice. Immunol Today (1989) 1.25
The peritoneal Ly-1 (CD5) B cell repertoire is unique among murine B cell repertoires. Eur J Immunol (1990) 1.25
Production of RNA for secreted immunoglobulin mu chains does not require transcriptional termination 5' to the microM exons. Nature (1983) 1.24
Increased nicotinamide nucleotide transhydrogenase levels predispose to insulin hypersecretion in a mouse strain susceptible to diabetes. Diabetologia (2007) 1.23
A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol (2001) 1.22
Contact sensitivity to azobenzenearsonate and its inhibition after interaction of sensitized cells with antigen-conjugated cells. J Exp Med (1981) 1.22
Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype. Genes Immun (2004) 1.18
SP-40,40 is an inhibitor of C5b-6-initiated haemolysis. Int Immunol (1989) 1.17
The murine Fc receptor for immunoglobulin: purification, partial amino acid sequence, and isolation of cDNA clones. Proc Natl Acad Sci U S A (1986) 1.17
Disordered "fibrinolytic potential" in coronary heart disease. Thromb Res (1977) 1.16
Prevalence of antithrombin deficiency in the healthy population. Br J Haematol (1994) 1.13
Human seminal clusterin (SP-40,40). Isolation and characterization. J Clin Invest (1990) 1.12
Acylated streptokinase--plasminogen complex in patients with acute myocardial infarction. Thromb Haemost (1984) 1.08
'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective. Vox Sang (2004) 1.08
Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for Haematology. J Clin Pathol (1993) 1.06
Characterization of a 95,000 molecule on sheep leucocytes homologous to murine Pgp-1 and human CD44. Immunology (1988) 1.06
Freeze dried cryoprecipitate: a clinical evaluation. J Clin Pathol (1983) 1.04
Evaluation of an automated prothrombin assay using a chromogenic substrate. Haemostasis (1984) 1.04
pMGA phenotypic variation in Mycoplasma gallisepticum occurs in vivo and is mediated by trinucleotide repeat length variation. Infect Immun (2000) 1.03
C57BL/6 and C57BL/10 inbred mouse strains differ at multiple loci on chromosome 4. Immunogenetics (1994) 1.03
A transgenic approach to the study of peripheral T-cell tolerance. Immunol Rev (1991) 1.03
Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost (1998) 1.03
The keratin chains of avian scale tissue. Sequence heterogeneity and the number of scale keratin genes. Eur J Biochem (1976) 1.02
Induction of delayed-type hypersensitivity to azobenzenearsonate by a monoclonal anti-idiotype antibody. J Exp Med (1981) 1.02
The Type I Diabetes Genetics Consortium 'Rapid Response' family-based candidate gene study: strategy, genes selection, and main outcome. Genes Immun (2009) 0.98
Immunoglobulin Cmu RNA in T lymphoma cells is not translated. Nature (1980) 0.98
The W and L allelic forms of phenylalanine hydroxylase in the rat differ by a threonine to isoleucine substitution. Biochem J (1986) 0.98
The immunoreactive 116 kDa surface protein of Mycoplasma pneumoniae is encoded in an operon. Microbiology (1997) 0.97
Polymorphisms in the Il12b gene affect structure and expression of IL-12 in NOD and other autoimmune-prone mouse strains. Genes Immun (2002) 0.97
Allelic forms of beta 2-microglobulin in the mouse. Proc Natl Acad Sci U S A (1980) 0.96
SP-40,40, a protein involved in the control of the complement pathway, possesses a unique array of disulphide bridges. FEBS Lett (1992) 0.96
Identification of Mycoplasma synoviae immunogenic surface proteins and their potential use as antigens in the enzyme-linked immunosorbent assay. Avian Dis (1996) 0.96
Overview of the Type I Diabetes Genetics Consortium. Genes Immun (2009) 0.95
Prevalence of the post-thrombotic syndrome in young women with previous venous thromboembolism. Br J Haematol (2000) 0.95
Comparison of thymic and peripheral T cell Ly-2/3 antigens. Eur J Immunol (1984) 0.95
Ly antigens associated with T cell recognition and effector function. Immunol Rev (1984) 0.94
Confirmation of novel type 1 diabetes risk loci in families. Diabetologia (2012) 0.93
The subunits of rabbit-muscle phosphofructokinase. A search for sequence repetition. Eur J Biochem (1976) 0.93
The secreted cathepsin L-like proteinases of the trematode, Fasciola hepatica, contain 3-hydroxyproline residues. Biochem J (1994) 0.92
Several vascular complement inhibitors are present on human sperm. Biol Reprod (1993) 0.92
The amino-terminal sequences of Ly-2 and Ly-3. Immunogenetics (1986) 0.92
Sexing single larval stages of Schistosoma mansoni by polymerase chain reaction. Mol Biochem Parasitol (1991) 0.91
Acquired transient protein C deficiency in neonatal cardiac failure. Arch Dis Child (1990) 0.91
rs2476601 T allele (R620W) defines high-risk PTPN22 type I diabetes-associated haplotypes with preliminary evidence for an additional protective haplotype. Genes Immun (2009) 0.90
Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series. BJOG (2002) 0.90
Monozygotic twins discordant for congenital complete heart block. Arthritis Rheum (1997) 0.89
Extrathymic acquisition of tolerance by T lymphocytes. Cold Spring Harb Symp Quant Biol (1989) 0.89
Abnormal coagulation and deep venous thrombosis in patients with advanced cancer. Clin Lab Haematol (1999) 0.89
The L3T4 antigen in mouse and the sheep equivalent are immunoglobulin-like. Immunogenetics (1986) 0.88
A search for messenger RNA molecules bearing immunoglobulin VH nucleotide sequences in T cells. J Exp Med (1982) 0.88
Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy. BJOG (2000) 0.88
Results of the MHC fine mapping workshop. Diabetes Obes Metab (2009) 0.87
Selection of the T-cell repertoire in transgenic mice expressing a transplantation antigen in distinct thymus subsets. Proc Biol Sci (1990) 0.87
mu Polypeptide phenotypes of lymphoid and myeloid cell lines containing RNA transcripts of the immunoglobulin C mu gene. J Immunol (1981) 0.87
Association analyses of the vitamin D receptor gene in 1654 families with type I diabetes. Genes Immun (2009) 0.86
Localization of Idd11 using NOD congenic mouse strains: elimination of Slc9a1 as a candidate gene. Immunogenetics (2000) 0.86
Platelet function testing: practice among UK National External Quality Assessment Scheme for Blood Coagulation participants, 2006. J Clin Pathol (2008) 0.86
Prostacyclin in cardiopulmonary bypass operations. J Thorac Cardiovasc Surg (1982) 0.86
Influence of demographic factors on antithrombin III activity in a healthy population. Br J Haematol (1993) 0.86
Hereditary thrombophilia and fetal loss: a prospective follow-up study. J Thromb Haemost (2004) 0.86
Thrombophilia and venous thromboembolism after total hip or knee replacement surgery: a systematic review. J Thromb Haemost (2005) 0.85